We serve D-Lysine Monohydrochloride CAS:7274-88-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
D-Lysine Monohydrochloride
CAS RN: 7274-88-6
| Solubility in water | Colorless & clear (c=5) |
| Specific rotation [α]D20 | -20.2°～-21.5°(c=8, 6M-HCl) |
| Loss on drying | Not more than 1.0% |
| Residue on ignition (as sulfate) | Not more than 0.1% |
| Sulfate (SO4) | Not more than 0.03% |
| Heavy metals (as Pb) | Not more than 10ppm |
| Iron (Fe) | Not more than 10ppm |
| Ammonium (NH4) | Not more than 0.02% |
| Arsenic (As2O3) | Not more than 1ppm |
| Other amino acids | Not detected by T.L.C.(The spotted amount, 20μg) |
| Assay | 98.5%～101.0% |
| L-Isomer | Not more than 0.5% |
Contact us for information like D-Lysine Monohydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,D-Lysine monohydroch physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,D-Lys.HCl Use and application,D-Lysine Monohydrochloride technical grade,usp/ep/jp grade.
Related News: Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.L-Homoserine manufacturer The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.3-(2-Methoxy-5-methylphenyl)-3-phenyl-propanoic Acid supplier As far as chemical raw materials are concerned, China occupies a large share in the field of bulk raw materials and has become one of the world’s largest suppliers of chemical raw materials.3-Bromophenylboronic acid vendor The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.Health officials said it remained unclear where he had developed the disease.
